Gyre Therapeutics's total assets for Q4 2024 were $125.41M, an increase of 0.13% from the previous quarter. GYRE total liabilities were $27.00M for the fiscal quarter, a 0.89% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.